Stress Hyperglycemia. Potential Role of Incretin Analogs
Launched by HOSPITAL UNIVERSITARI SON DURETA · Mar 15, 2010
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18 years
- • Emergent ICU admission
- • Written informed consent from patient or relative.
- Exclusion Criteria:
- • Previously known type I or type II diabetes.
- • Patients who received insulin or oral antidiabetic agents before ICU admission.
- • Malignancies.
- • Scheduled surgery
- • Patients receiving enteral or parenteral nutrition.
- • Inability to obtain informed consent.
About Hospital Universitari Son Dureta
Hospital Universitari Son Dureta is a leading academic medical center located in Palma de Mallorca, Spain, dedicated to advancing healthcare through innovative research and clinical trials. With a commitment to excellence in patient care and medical education, the hospital collaborates with various stakeholders to explore new therapies and treatment modalities across multiple specialties. Its robust infrastructure, coupled with a team of experienced clinicians and researchers, positions Hospital Universitari Son Dureta as a pivotal institution in the realm of clinical research, contributing to the enhancement of medical knowledge and patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Palma De Mallorca, Illes Balears, Spain
Patients applied
Trial Officials
Juan A Llompart-Pou, M.D.
Principal Investigator
Hospital Universitari Son Dureta. Intensive Care Unit
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials